Cargando…

Full thickness macular hole case after intravitreal aflibercept treatment

BACKGROUND: The pathogenesis of macular hole formation is widely accepted as a tractional force at the vitreo-retinal interface in fovea. We report a case of macular hole after intravitreous aflibercept injection for age-related macular degeneration (AMD) associated with contraction of the retinal p...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Yuji, Apte, Rajendra S, Nakao, Shintaro, Yoshida, Shigeo, Ishibashi, Tatsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381494/
https://www.ncbi.nlm.nih.gov/pubmed/25881212
http://dx.doi.org/10.1186/s12886-015-0021-3
_version_ 1782364462066434048
author Oshima, Yuji
Apte, Rajendra S
Nakao, Shintaro
Yoshida, Shigeo
Ishibashi, Tatsuro
author_facet Oshima, Yuji
Apte, Rajendra S
Nakao, Shintaro
Yoshida, Shigeo
Ishibashi, Tatsuro
author_sort Oshima, Yuji
collection PubMed
description BACKGROUND: The pathogenesis of macular hole formation is widely accepted as a tractional force at the vitreo-retinal interface in fovea. We report a case of macular hole after intravitreous aflibercept injection for age-related macular degeneration (AMD) associated with contraction of the retinal pigment epithelium (RPE) at the edge of a fibrovascular pigment epithelial detachment (PED). CASE PRESENTATION: A 94-year old man with neovascular AMD affecting his left eye accompanied by a fibrovascular PED was examined for severe vision loss. Although RPE tear in his left eye was identified before the first aflibercept intravitreous injection performed in order to treat neovascular AMD, he received three aflibercept injections as induction treatment. After induction treatment, a full thickness macular hole was identified associated with the contracted rolled RPE edge beneath the retina. CONCLUSION: Macular hole is commonly formed associated with tangential vitreous traction. Current report suggests that rapid contraction of the RPE underneath the retina can be one of the causes of a macular hole, and one of the side effects of anti-VEGF therapy for neovascular AMD.
format Online
Article
Text
id pubmed-4381494
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43814942015-04-02 Full thickness macular hole case after intravitreal aflibercept treatment Oshima, Yuji Apte, Rajendra S Nakao, Shintaro Yoshida, Shigeo Ishibashi, Tatsuro BMC Ophthalmol Case Report BACKGROUND: The pathogenesis of macular hole formation is widely accepted as a tractional force at the vitreo-retinal interface in fovea. We report a case of macular hole after intravitreous aflibercept injection for age-related macular degeneration (AMD) associated with contraction of the retinal pigment epithelium (RPE) at the edge of a fibrovascular pigment epithelial detachment (PED). CASE PRESENTATION: A 94-year old man with neovascular AMD affecting his left eye accompanied by a fibrovascular PED was examined for severe vision loss. Although RPE tear in his left eye was identified before the first aflibercept intravitreous injection performed in order to treat neovascular AMD, he received three aflibercept injections as induction treatment. After induction treatment, a full thickness macular hole was identified associated with the contracted rolled RPE edge beneath the retina. CONCLUSION: Macular hole is commonly formed associated with tangential vitreous traction. Current report suggests that rapid contraction of the RPE underneath the retina can be one of the causes of a macular hole, and one of the side effects of anti-VEGF therapy for neovascular AMD. BioMed Central 2015-03-29 /pmc/articles/PMC4381494/ /pubmed/25881212 http://dx.doi.org/10.1186/s12886-015-0021-3 Text en © Oshima et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Oshima, Yuji
Apte, Rajendra S
Nakao, Shintaro
Yoshida, Shigeo
Ishibashi, Tatsuro
Full thickness macular hole case after intravitreal aflibercept treatment
title Full thickness macular hole case after intravitreal aflibercept treatment
title_full Full thickness macular hole case after intravitreal aflibercept treatment
title_fullStr Full thickness macular hole case after intravitreal aflibercept treatment
title_full_unstemmed Full thickness macular hole case after intravitreal aflibercept treatment
title_short Full thickness macular hole case after intravitreal aflibercept treatment
title_sort full thickness macular hole case after intravitreal aflibercept treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381494/
https://www.ncbi.nlm.nih.gov/pubmed/25881212
http://dx.doi.org/10.1186/s12886-015-0021-3
work_keys_str_mv AT oshimayuji fullthicknessmacularholecaseafterintravitrealaflibercepttreatment
AT apterajendras fullthicknessmacularholecaseafterintravitrealaflibercepttreatment
AT nakaoshintaro fullthicknessmacularholecaseafterintravitrealaflibercepttreatment
AT yoshidashigeo fullthicknessmacularholecaseafterintravitrealaflibercepttreatment
AT ishibashitatsuro fullthicknessmacularholecaseafterintravitrealaflibercepttreatment